We studied the three patient-derived mesenchymal GBM cell lines G411, G729, G797 with high native expression of GJB2 and SCN9A (Lan et al, 2017; Meyer et al, 2015; Park et al, 2017). The gene discussed is GJB2; the disease is glioblastoma.